CALC

CalciMedica, Inc.
CAPPED RATING

CalciMedica, Inc. (CALC) is rated D+ (1.6/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Revisions (C+); its weakest is Profitability (F). The rating has held at D+ for 2 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
1.6 / 5.0
D+
Value
C+
Factor Score 2.5 / 5.0
Growth
D+
Factor Score 1.5 / 5.0
Profitability
F
Factor Score 0.4 / 5.0
Momentum
F
Factor Score 0.7 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio -0.5
EV / EBITDA -0.1
Rev Growth YoY N/A
Gross Margin 0.0%
Price Return 3M -62.7%
Price Return 12M -92.6%
Catalyst Signal 0.00
Market Cap $8.2M
TTM Revenue N/A
Price / Sales N/A
ROE N/M

Historical Factor Score Progression

Held D+ for 2 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-17 C+ (2.5) D+ (1.5) F (0.4) F (0.7) C+ (2.6) D+ (1.6)
2026-11-10 C+ (2.5) C- (1.9) D (1.2) D- (0.9) C+ (2.6) D+ (1.8)
2026-11-03 C+ (2.5) D+ (1.8) D (1.4) D- (0.8) C+ (2.7) D+ (1.8)
2026-10-27 B+ (3.7) C- (1.9) D (1.3) D- (0.8) C+ (2.6) C- (2.0)
2026-10-20 B+ (3.7) D+ (1.8) D (1.3) F (0.7) C+ (2.6) C- (2.0)
Page 1 of 4